Results 171 to 180 of about 308,269 (193)

Immunotherapy in the perioperative management of esophageal squamous cell carcinoma: recent developments. [PDF]

Front Oncol
Sun M, Yang P, Yang T, Zhang J, Li H, Li Y, Zhu B.   +6 more
europepmc   +1 more source

Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancer patients with prior anthracycline exposure

, 2000
M. Martín, Aña Lluch, Antonio Casado, Iciar Garcı́a Carbonero, Lucía Paz, Carmen Esteban, Amelia Insa, Rosario Alfonso, J Garcı́a-Conde, Eduardo Díaz‐Rubio   +9 more
openalex   +1 more source

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer

, 2000
Tommaso De Pas, Filippo de Braud, Romano Danesi, C. Sessa, Chiara Catania, Giuseppe Curigliano, Stefano Fogli, Mario Del Tacca, G. Zampino, Alberto Sbanotto, Andrea Rocca, Saverio Cinieri, E. Marrocco, Andrea Milani, Aron Goldhirsch   +14 more
openalex   +1 more source

Effect of intrapleural anti-Vascular Endothelial Growth Factor (VEGF) associated with nab paclitaxel in a murine model of malignant pleural effusion. [PDF]

BMC Cancer
Silva CSR, Teixeira LR, Pereira KR, Figueiredo Braga Colares P, Alvarenga VA, Sales RKB, Roque AC, Marchi E, Mamoni RL, Pagliarelli Acencio MM.   +9 more
europepmc   +1 more source

Correction: Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis. [PDF]

Front Pharmacol
Ma Y, Li J, Liu L, Shen T.
europepmc   +1 more source

Dual Therapeutic Impact of AXL Inhibitor AB-329: Chemotherapy Sensitization and Immune Microenvironment Reprogramming in TNBC. [PDF]

Int J Mol Sci
Rampa DR, Fuson JA, Liu H, Pan M, Qin Y, Deng Y, Ueno NT, Lee J.   +7 more
europepmc   +1 more source

Development of Drug-resistant Cell Lines for Experimental Procedures. [PDF]

J Vis Exp
Kadomoto S, Shelley G, Mizokami A, Keller ET.   +3 more
europepmc   +1 more source

Application of chemotherapy combined with immunotherapy in first-line treatment of advanced esophageal cancer: fluorouracil or paclitaxel? - a meta-analysis. [PDF]

Front Oncol
Chen X, Yan H, Zhao H, Zhu P.
europepmc   +1 more source

Metronomic chemotherapy of paclitaxel plus cisplatin in patients with metastatic breast cancer: a target trial emulation study. [PDF]

Ther Adv Med Oncol
Li Y, Zhu L, Ma J, Wang Y, Lin Y, Ye Y, Zhou L, Yin W, Lu J, Wang Y.   +9 more
europepmc   +1 more source